Skip to page content

USA Banner

Official US Government Icon

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure Site Icon

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Site Notification

Site Notification

United States Department of TransportationUnited States Department of Transportation

Guide for Aviation Medical Examiners

Decision Considerations - Aerospace Medical Dispositions
Item 48. General Systemic - Human Immunodeficiency Virus (HIV)

Human Immunodeficiency Virus (HIV) - All Classes

Disease/Condition Evaluation Data Disposition
HIV medication taken for long-term prevention or Pre-Exposure Prophylaxis (PrEP)* in an HIV negative airman

*Note: This does NOT include use for short-term Post- Exposure Prophylaxis (PEP) - (ex: healthcare exposure.)

Review a current status report from the prescribing physician that verifies:

☐ HIV status is negative;

☐ Appropriate lab studies are being monitored;

☐ Medication is Truvada (tenofovir-emtricitabine), Descovy (emtricitabine and tenofovir alafenamide) or Apretude (cabotegravir); and

☐ No side effects from the medication.

Note this in Block 60 and submit the initial current status and lab report to FAA for retention in the airman's file.

Inform the airman that if they develop any problems with the medication, change in prophylactic medications, or seroconvert to HIV+ status, they must report this to the FAA.

For continued certification: If no change in medication and HIV status remains negative, the AME may issue. Note this in Block 60.

Human Immunodeficiency Syndrome (HIV)

Use this disposition if the airman has a history of HIV only

See HIV Protocol DEFER
Requires FAA Decision
Acquired Immunodeficiency Syndrome (AIDS)

Use this disposition if the airman has EVER had a history of AIDS

See HIV Protocol DEFER
Requires FAA Decision

Page last modified: